Brachial artery PWV has been reported to change less with age than PWV in the aorta or lower limb arteries. However, this was irrelevant to the hypothesis and in no way detracts from the importance of our results that subsequently were confirmed by Wilkinson et al in sheep. Our group and many others have shown that endothelium-derived nitric oxide has similar important functions in coronary and peripheral arteries in vivo and in arteries from other beds ex vivo. 3 By improving arterial elasticity, endothelium-derived nitric oxide reduces the arterial wave reflection and reduces left ventricular work and the pulse pressure within the aorta. 4 These likely have important consequences for cardiovascular outcomes.
Although we agree with Wilkinson et al that the infusion of any substance, including L-NMMA, could potentially lead to changes in shear stress and blood flow, we disagree that this was not controlled for in our study. Our assessment of arterial elasticity was always compared with a control infusion of dextrose at the same infusion rate as the subsequent L-NMMA and nitroglycerin infusions and was equivalent to approximately 1% to 2% of brachial artery flow. Furthermore, our technique of assessing arterial elasticity is independent of blood flow, as it is a direct assessment of arterial distension (using intravascular ultrasound to image the artery wall) with simultaneous intra-arterial pressure measurements. In contrast, the assessment of distensibility using PWV is indirect and potentially affected by changes in blood flow and mean pressure that reflect changes in more distal resistance vessels. 5 Their method relies on measuring the time taken for the arterial pressure wave to progress between two transducers placed on a 6 French catheter sitting within a 7 French sheath (approximately 2.5 mm external diameter) inserted into the iliac artery of sheep. 2 Their demonstration that the effect of acetylcholine (a known stimulus for endothelium-derived nitric oxide) was blocked by the competitive inhibitor of nitric oxide (L-NMMA) was not unexpected and has been demonstrated by our group and others for a number of functions regulated by endothelium-derived nitric oxide. 6,7 Therefore, we omitted this test in our study of humans, which was designed to examine the role in resting basal conditions.
We are unable to comment on whether their modification of the technique for measuring PWV has any value in measuring endothelial function because these data are unpublished. The assumptions required for an indirect assessment of endothelial vasodilator function would have to be remarkably robust to measure the small changes seen in even healthy people. Other noninvasive techniques that are able to directly measure arterial distension include ultrasound techniques such as wall-tracking and application tonometry. The reliance on any one technique would be a mistake in our view because they all have advantages and disadvantages.
Arterial elasticity is an important contributor to cardiovascular outcomes. 8 While it is interesting to conduct research in sheep, species differences may exist; therefore, it is critically important to study these mechanisms in humans. Our study reminds us that therapies that improve endothelial function are likely to contribute to a reduction in adverse outcomes in patients because of their effect on elasticity as well as on other local arterial functions. It is the right idea, regardless of the vascular bed.
